ArticleCureus2025
Aspirin Desensitization in the Course of Non-ST-Segment Elevation Acute Coronary Syndrome: A Case Report and Review of the Literature.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antiplatelet therapy is essential for patients with acute coronary syndrome (ACS). Aspirin (acetylsalicylic acid, or ASA) is one of the most commonly used medications for this purpose, particularly in the context of dual antiplatelet therapy (DAPT). However, hypersensitivity to aspirin can pose significant challenges, especially when this treatment is indispensable. This report discusses the case of a patient with non-ST-segment elevation myocardial infarction (NSTEMI) who presented with an allergic reaction to aspirin. An aspirin desensitization protocol was successfully implemented, allowing for the initiation of DAPT following dual angioplasty. This case highlights the importance and feasibility of aspirin desensitization in ensuring optimal management of patients with aspirin allergy, in a cardiac emergency setting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.